A Generic System for the Expression and Purification of Soluble and Stable Influenza Neuraminidase
Author Information
Author(s): Peter M. Schmidt, Rebecca M. Attwood, Peter G. Mohr, Susan A. Barrett, Jennifer L. McKimm-Breschkin
Primary Institution: CSIRO, Parkville, Victoria, Australia
Hypothesis
The study aims to develop a generic expression system for producing stable and soluble influenza neuraminidase.
Conclusion
The developed expression system can produce high yields of stable and soluble neuraminidase suitable for various applications.
Supporting Evidence
- The expression system can produce milligram amounts of recombinant neuraminidase.
- Recombinant neuraminidase showed biochemical properties closer to the original viral enzyme.
- The Tetrabrachion stalk provided higher stability compared to the GCN4 stalk.
- Both constructs 2 and 4 retained activity in insect cell media for weeks.
- Milligram amounts of construct 4 NA per litre of insect cell culture were obtained.
Takeaway
Scientists created a new way to make a key protein from the flu virus that can help in making vaccines and medicines.
Methodology
The study used a baculovirus expression vector system to produce recombinant neuraminidase with different artificial stalks for stability.
Limitations
The study does not address the long-term stability of the expressed proteins under various conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website